Literature DB >> 12545073

Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials.

Donald P Francis, William L Heyward, Vladimir Popovic, Patti Orozco-Cronin, Karin Orelind, Carolyn Gee, Adrian Hirsch, Tina Ippolito, Aimee Luck, Michael Longhi, Vineeta Gulati, Nathan Winslow, Marc Gurwith, Faruk Sinangil, Phillip W Berman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12545073     DOI： 10.1097/01.aids.0000050786.28043.62

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  27 in total

1.  The second wave will drown us.

Authors:  Michael Gross
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Authors:  Paula M Frew; Matthew Archibald; Nina Martinez; Carlos del Rio; Mark J Mulligan
Journal:  Challenge (Atlanta Ga)       Date:  2007

Review 3.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 4.  Practice brief: adolescents and HIV clinical trials: ethics, culture, and context.

Authors:  Kathleen M MacQueen; Quarraisha Abdool Karim
Journal:  J Assoc Nurses AIDS Care       Date:  2007 Mar-Apr       Impact factor: 1.354

5.  HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion.

Authors:  Kathleen Johnston Roberts; Peter A Newman; Naihua Duan; Ellen T Rudy
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

6.  Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Authors:  Thomas M Lampinen; Keith Chan; Robert S Remis; Maraki Fikre Merid; Melanie Rusch; Jean Vincelette; Ken Logue; Vladimir Popovic; Michel Alary; Martin T Schechter; Robert S Hogg
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

7.  Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes.

Authors:  Timothy Cardozo; Shixia Wang; Xunqing Jiang; Xiang-Peng Kong; Catarina Hioe; Chavdar Krachmarov
Journal:  Vaccine       Date:  2014-07-18       Impact factor: 3.641

8.  HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.

Authors:  Peter A Newman; Naihua Duan; Sung-Jae Lee; Ellen T Rudy; Danielle S Seiden; Lisa Kakinami; William E Cunningham
Journal:  Vaccine       Date:  2005-11-21       Impact factor: 3.641

9.  Recruitment of Caribbean female commercial sex workers at high risk of HIV infection.

Authors:  Marie Marcelle Deschamps; Carmen D Zorrilla; Cecilia A Morgan; Yeycy Donastorg; Barbara Metch; Tamra Madenwald; Patrice Joseph; Karine Severe; Sheyla Garced; Marta Perez; Gina Escamilia; Edith Swann; Jean William Pape
Journal:  Rev Panam Salud Publica       Date:  2013-08

10.  In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study.

Authors:  Paula M Frew; Wendy Macias; Kayshin Chan; Ashley C Harding
Journal:  J Health Mass Commun       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.